MedPath

Sevoflurane

Sevoflurane, USP Volatile Liquid for Inhalation

Approved
Approval ID

06b9f724-6425-4976-93eb-b9ca343ef5cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 29, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sevoflurane

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72162-2245
Application NumberANDA077867
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 29, 2024
FDA Product Classification

INGREDIENTS (1)

SEVOFLURANEActive
Quantity: 1 mL in 1 mL
Code: 38LVP0K73A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sevoflurane - FDA Drug Approval Details